Penserra Capital Management’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,978
Closed -$733K 1104
2025
Q2
$733K Sell
20,978
-46,181
-69% -$1.52M 0.01% 460
2025
Q1
$2.43M Buy
+67,159
New +$2.07M 0.04% 276
2021
Q4
Sell
-1,585
Closed -$167K 1576
2021
Q3
$167K Buy
1,585
+190
+14% +$27.3K ﹤0.01% 648
2021
Q2
$246K Buy
1,395
+45
+3% +$7.24K ﹤0.01% 596
2021
Q1
$180K Buy
1,350
+75
+6% +$11.6K ﹤0.01% 601
2020
Q4
$172K Buy
1,275
+805
+171% +$81.9K ﹤0.01% 555
2020
Q3
$39K Buy
+470
New +$37.7K ﹤0.01% 661

Other funds holding ZLAB

Penserra Capital Management's ZLAB Position: Q3 2025 in Review

Penserra Capital Management sold out of Zai Lab (ZLAB) in Q3 2025, closing a stake of 20,978 shares — an estimated $733K sold.

Penserra Capital Management first reported a position in ZLAB in Q3 2020 and held it in 7 quarters. The position peaked at $2.43M in Q1 2025. 138 funds tracked by Wall St. Rank hold ZLAB as of Q3 2025.

  • Penserra Capital Management reported no remaining Zai Lab position as of Q3 2025 after selling out during the quarter.
  • Penserra Capital Management sold 20,978 Zai Lab shares in Q3 2025, an estimated $733K.
  • Penserra Capital Management first reported a position in Zai Lab in Q3 2020 and held it in 7 quarters.
  • Penserra Capital Management's Zai Lab position peaked at $2.43M in Q1 2025.
  • 138 funds tracked by Wall St. Rank held Zai Lab as of Q3 2025.

Based on Penserra Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.